订购信息
上海拜力生物科技公司
Tel:400-968-7988    021-33779008
Neural-LSB
品牌:Xcessbio
货号:S10001
规格:1000X; 0.5 ml
货期:

Neural-LSB

商品详情 参考文献 相关资料
Product Information
Purity: ≥98% for each compound
Storage: 4oC for 3 month. -20oC for 6 month.
Cocktail Formulation: 0.1 mM LDN-193189 and 10 mM SB431542 in DMSO solution
Effective Concentration in Cell Culture: 0.1 µM LDN-193189 and 10 µM SB431542 in cell culture medium

Biological Activity:

Differentiation of human pluripotent stem cells (hPSCs) requires precise signaling control at each step to mimic the embryonic development. Advances in using highly specific and potent small molecule modulators of signaling pathways have allowed efficient generation of nearly homogenous populations of specific cell types from hPSCs. For highly efficient conversion of hESCs/iPSCs into neural precursor cells in a monolayer fashion, inhibition of both BMP and TGFβ signaling pathways (i.e., dual SMAD inhibition) by small molecule inhibitors, LDN-193189 (0.1 µM) and SB431542 (10 µM) respectively (i.e., Neural-LSB), was developed as the most effective condition. Under this dual SMAD inhibition using the Neural-LSB small molecule cocktail, more than 80% of hPSCs are rapidly induced into Pax6+ neural precursor cells. This condition can be further combined with other patterning cues to generate subtype specific neural and neuronal cells, such as floor plate and midbrain dopaminergic neurons using Hedgehog and Wnt pathway activators (i.e., purmorphamine and CHIR99021), or nociceptors using 3i (combination of CHIR99021/GSK3 inhibitor, SU5402/FGF-VEGF-PDGF inhibitor, DAPT/Notch inhibitor). 

XcessBio’s Neural-LSB contains the combination of LDN193189/BMP inhibitor and SB431542/TGFβ inhibitor.


How to Use:

  • In vitro: Simply add/dilute the received LSB stock solutions at 1:1000 into your hESC/iPSC differentiation basal media to make the LSB induction media and use it to initiate neural differentiation.

Reference:

  • 1.  Chambers, S.M. et al. Combined small-molecule inhibition accelerates developmental timing and converts human pluripotent stem cells into nociceptors. (2012) Nature Biotechnology 30, 715-720.

  • 2.  Chambers, S.M. et al. Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling. (2009) Nat. Biotechnol. 27, 275–280.

  • 3.  Yu, P.B. et al. BMP type I receptor inhibition reduces heterotopic [corrected] ossification. (2008) Nat. Med. 14, 1363–1369.


  • Product Specification:
  • Product MSDS:



Products are for research use only. Not for human use.

热销产品
热销产品排行榜
  • 关于我们
  • 购物流程
  • 支付方式
  • 配送方式

请打开QQ扫码联系
Copyright@ 2003-2025  进口试剂采购网版权所有     

BIOLEAF热搜   BIOLEAF试剂盒   BIOLEAF ELISA   BIOLEAF试剂   BIOLEAF品牌   BIOLEAF抗体   BIOLEAF耗材   BIOLEAF小仪器

sitemap   细胞库查询   危险品图标

本公司网站所展示销售的产品仅供科研!

         沪ICP备08023583号-6     
产品咨询
QQ扫码沟通
在线客服
服务电话
400-968-7988
扫码关注
微信公众号二维码

沪公网安备 31011202007338号